Determinants of clinical outcome in high grade serous ovarian cancer

被引：0
|
作者：
Bowtell, David D. L. [1 ]
Cown, Prue [1 ]
Etemadmoghadam, Dariush [1 ]
Alsop, Kathryn [1 ]
George, Joshy [1 ]
de Fazaio, Anna [2 ]
Mitchell, Gillian [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Westmead Inst Canc Reseach, Sydney, NSW, Australia
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5082
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Determinants of resistance and response in high-grade serous ovarian cancer
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [2] A 2-Protein Signature Predicting Clinical Outcome in High-Grade Serous Ovarian Cancer
    Jin, Chengjuan
    Xue, Yingfeng
    Li, Yingwei
    Bu, Hualei
    Yu, Hongfeng
    Zhang, Tao
    Zhang, Zhiwei
    Yan, Shi
    Lu, Nan
    Kong, Beihua
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (01) : 51 - 58
  • [3] Toxicity and Therapy Outcome Associations in High-grade Serous Ovarian Cancer
    Deng, F.
    Laasik, M.
    Salminen, L.
    Lapatto, L.
    Huhtinen, K.
    Li, Y.
    Hautaniemi, S.
    Hynninen, J.
    Niemi, M.
    Lehtonen, R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S96 - S96
  • [4] The clinical outcome of FAP plus cancer-associated fibroblasts in high-grade serous ovarian cancer.
    Dahlstrand, Hanna
    Corvigno, Sara
    Mezheyeuski, Artur
    Carlson, Joseph W.
    Fernebro, Josefin
    Holzlwimmer, Gabriele
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Hormonal receptor expression and clinical outcome in ovarian high-grade serous carcinoma
    George, S.
    Sowamber, R.
    Dodds, L.
    Jordan, S. E.
    Paudel, I.
    Huang, M.
    Pinto, A.
    Schlumbrecht, M. P.
    Shaw, P.
    Slomovitz, B. M.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 73 - 73
  • [6] Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation
    Lana E. Kandalaft
    Denarda Dangaj Laniti
    George Coukos
    Nature Reviews Cancer, 2022, 22 : 640 - 656
  • [7] Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation
    Kandalaft, Lana E.
    Laniti, Denarda Dangaj
    Coukos, George
    NATURE REVIEWS CANCER, 2022, 22 (11) : 640 - 656
  • [8] Low grade serous ovarian cancer: Unpicking drivers of outcome
    Gourley, Charlie
    Hollis, Robert L.
    GYNECOLOGIC ONCOLOGY, 2022, 167 (02) : 137 - 138
  • [9] Determinants of clinical outcome in ovarian cancer
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [10] Expression of Galectins in high grade serous ovarian cancer
    Labrie, Marilyne
    Communal, Laudine
    Vladoiu, Maria-Claudia
    Dupont, Pascal
    Mes-Masson, Anne-Marie
    St-Pierre, Yves
    CANCER RESEARCH, 2016, 76
12345